Childhood Vaccination: A Growing Concern

Overview of the Vaccination Debate

Childhood vaccination remains a contentious issue, particularly concerning the measles, mumps, and rubella (MMR) vaccine. Recent findings indicate that a decline in MMR vaccine coverage can lead to a significant rise in measles cases and increased healthcare costs.

Decline in Vaccination Rates

Globally, there has been a noticeable decrease in the number of children receiving routine vaccinations. In the United States, an increasing number of parents are opting for non-medical and personal exemptions, despite a robust body of scientific evidence affirming the safety and efficacy of vaccines. Concerns are mounting that any relaxation of childhood vaccination requirements may exacerbate this decline, resulting in higher incidences of infectious diseases, particularly measles.

Study Insights from JAMA Pediatrics

A recent study published in JAMA Pediatrics utilized a theoretical modeling approach to assess the public health and economic impacts of MMR vaccine hesitancy, defined as reluctance to vaccinate due to personal beliefs. The research relied on data from the U.S. Centers for Disease Control and Prevention (CDC) to estimate MMR vaccine coverage among children aged 2 to 11 years across 257 counties in the U.S. Various scenarios were analyzed to predict the consequences of measles introductions in these regions, considering different levels of vaccine hesitancy and the potential effects of removing non-medical exemptions.

Current Vaccination Rates and Measles Cases

According to the latest U.S. data, approximately 93% of children aged 2 to 11 years have received the MMR vaccine. During the 2015-2016 period, there were 48 reported cases of measles and four outbreaks. A 5% reduction in MMR vaccine coverage could lead to an estimated rise in annual measles cases to 150, representing a threefold increase. This surge would incur additional public sector costs of approximately $2.1 million, based on an estimated cost of $20,000 per case.

Impact of Expanding Age Range

When the age range is broadened to include unvaccinated infants (0-11 years), the projected number of measles cases and associated costs escalates further. The anticipated figures would likely be even higher if adolescents and adults were included in the analysis.

Benefits of Eliminating Non-Medical Exemptions

In contrast, if non-medical exemptions were eliminated, MMR vaccine coverage could see an increase to 95%. This change is expected to lead to a 20% reduction in annual measles cases, lowering the number from 48 to 38, along with corresponding decreases in healthcare costs.

Conclusion and Implications

Despite certain limitations, such as potential variations in county-specific data and the assumption that each county has a similar child demographic, the study highlights that measles poses a genuine threat to children if vaccination rates continue to decline. This underscores the necessity for addressing vaccine hesitancy at both state and national levels, with particular emphasis on reconsidering non-medical exemptions.

Written by Natasha Tetlow, PhD
Lo NC, Hotez PJ. Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatrics. 2017. Available at: doi: 10.1001/jamapediatrics.2017.1695